awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38185691-AA6F5782-FB2B-4C0F-8807-DFF47E5AB8EC
Q38185691-AA6F5782-FB2B-4C0F-8807-DFF47E5AB8EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38185691-AA6F5782-FB2B-4C0F-8807-DFF47E5AB8EC
Vandetanib for the treatment of thyroid cancer: an update.
P2860
Q38185691-AA6F5782-FB2B-4C0F-8807-DFF47E5AB8EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38185691-AA6F5782-FB2B-4C0F-8807-DFF47E5AB8EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6257afaa04d34e0f0d8c6f5cd0b730ce5a4c431b
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr